Actively Recruiting
Vitiligo, New Treatment and Serum s100B
Led by South Valley University · Updated on 2025-01-10
50
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
vitiligo is an autoimmune depigmenting skin disorder characterized by milky white macules or patches, with 2% worldwide prevalence. Vitiligo has unexpected course that significantly influences on patient's quality of life and self-esteem. Multiple medications have been introduced for vitiligo treatment, in this study we work on one of systemic JAK inhibitors
CONDITIONS
Official Title
Vitiligo, New Treatment and Serum s100B
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Active generalized vitiligo with more than 5% body surface area affected, excluding hands and feet
- No systemic vitiligo treatment in the last 3 months
- No topical vitiligo treatment in the last 4 weeks
- Age between 10 and 75 years
You will not qualify if you...
- Acrofacial, acral, segmental, or mucosal vitiligo
- Use of other immunosuppressive agents
- Other skin conditions affecting evaluation such as psoriasis, lupus, or alopecia areata
- Systemic diseases affecting s100B levels like subarachnoid hemorrhage, Alzheimer disease, or inflammatory diseases
- Other dermatological diseases affecting s100B like malignant melanoma
- Immunocompromised status or uncontrolled arterial hypertension
- Serious infections (viral, bacterial, fungal, parasitic), anemia, or history of thromboembolic events
- Cardiovascular, respiratory, hepatic, gastrointestinal, endocrine, hematological, lymphoproliferative, neurological, neuropsychiatric disorders, or other serious unstable illnesses
- Pregnancy or lactation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Qena university hospital, Qena faculty of medicine
Qina, Egypt
Actively Recruiting
Research Team
E
Eman A Osman, bachelor
CONTACT
H
Hassan mo farid, bachelor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here